ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,728.80
      0.41%
      US Tech 100
      19,497.20
      0.00%
      Dow Jones
      42,052.19
      0.69%
      Brent Oil
      74.575
      0.67%
      Bitcoin
      68,566.94
      -0.25%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. ETFs
      4. USA
      5. AMEX

      6. iShares Core Moderate Allocation ETF (AOM) Quote

      iShares Core Moderate Allocation ETF

      iShares Core Moderate Allocation ETF (AOM)

      Activeops Plc
      43.85
      0.00
      (0.00%)
      Closed November 04 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      43.85
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      38.86 52 Week Range 45.31
      Market Cap
      1.394B
      Previous Close
      43.85
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      87,447
      Shares Outstanding
      31,800,000
      Dividend Yield
      -
      PE Ratio
      10.26
      Earnings Per Share (EPS)
      4.27
      Revenue
      42.4M
      Net Profit
      135.92M

      About iShares Core Moderate Allocation ETF

      The investment seeks to track the investment results of the S&P Target Risk Moderate Index composed of a portfolio of underlying equity and fixed income funds intended to represent a moderate target risk allocation strategy. The fund is a fund of funds and seeks its investment objective by investing... The investment seeks to track the investment results of the S&P Target Risk Moderate Index composed of a portfolio of underlying equity and fixed income funds intended to represent a moderate target risk allocation strategy. The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 90% of its assets in the component securities of the underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model. Show more

      Sector
      Mgmt Invt Offices, Open-end
      Industry
      Mgmt Invt Offices, Open-end
      Website
      www.ishares.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      iShares Core Moderate Allocation ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker AOM. The last closing price for Moderate Allocation ETF was $43.85. Over the last year, Moderate Allocation ETF shares have traded in a share price range of $ 38.86 to $ 45.31.

      Moderate Allocation ETF currently has 31,800,000 shares outstanding. The market capitalization of Moderate Allocation ETF is $1.39 billion. Moderate Allocation ETF has a price to earnings ratio (PE ratio) of 10.26.

      AOM Latest News

      More News

      Business software firm ActiveOps raises GBP76 million in AIM float

      ActiveOps PLC said Thursday it has raise GBP75.7 million gross for selling shareholders in its initial public offerin ...

      March 25 2021
      Alliance News

      Target Allocation ETF Investing 101 - ETF News And Commentary

      In these volatile times, most investors are faced with the dilemma of deciding which asset class to put their hard earned capital to work in. During times of economic uncertainties, most...

      September 05 2012
      Zacks

      iShares Launches Multi-Asset, Global Junk Bond ETFs - ETF News And Commentary

      San Francisco-based iShares is the world’s largest exchange traded funds (ETFs) provider with 46% of the market share. It offers a variety of ETFs across different asset classes, sectors...

      April 15 2012
      Zacks

      Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

      SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical officer. Dr. Becker joins Koronis from AnorMED...

      October 26 2006
      PR Newswire (US)

      Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond

      Agreement Eliminates Development Milestones, Significantly Reduces Royalties and Restructures Sublicense Provisions SOUTH SAN FRANCISCO, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Poniard...

      September 19 2006
      PR Newswire (US)

      AnorMED shares begin trading on NASDAQ

      VANCOUVER, Sept. 7 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that its common shares will begin trading on September 8, 2006 on the NASDAQ Global Market of the...

      September 07 2006
      PR Newswire (US)

      AnorMED Board recommends shareholders reject hostile Genzyme offer and not tender shares

      VANCOUVER, Sept. 5 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) announced that its Board of Directors, based on the recommendation of its Strategic...

      September 05 2006
      PR Newswire (US)

      AnorMED advises shareholders to take no action on unsolicited takeover bid from Genzyme Corporation

      VANCOUVER, Sept. 1 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) today confirmed that Genzyme Corp. has commenced an unsolicited offer through a...

      September 01 2006
      PR Newswire (US)

      Genzyme to Initiate Tender Offer to Acquire AnorMED, Inc.

      Proposed Acquisition Will Add Complementary Late-Stage Transplant Product CAMBRIDGE, Mass., Aug. 30 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) announced today that it plans to...

      August 30 2006
      PR Newswire (US)

      AnorMED rejects unsolicited approach from Genzyme

      Considers Genzyme Proposal Undervalued VANCOUVER, Aug. 30 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) today announced that its Board of Directors has...

      August 30 2006
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.44-0.99345224655744.2944.309643.768111844.03628854SP
      4-0.64-1.4385255113544.4944.722343.769092944.35108407SP
      120.731.6929499072443.1245.3143.08958744744.36702234SP
      261.74.0332147093742.1545.3142.19870943.52788397SP
      524.7512.148337595939.145.3138.8614278641.96690192SP
      156-1.8-3.943044906945.6546.04535.7119327140.61813092SP
      2604.1410.425585494839.7146.04533.2519103440.84596553SP

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 13.54
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.14
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.99
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 1.01
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 13.54
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.14
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.99
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 1.01
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 13.54
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 64.14
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.99
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 1.01
      (0.00%)
      		0

      Discussion

      View Full Feed
      dennisdave dennisdave 4 minutes ago
      mmmmm

      DCVAXL trial
      Median OS (mOS) for the 232 patients with nGBM receiving DCVax-L was 19.3 (95% CI, 17.5-21.3) months

      SurVaxM is an experimental vaccine for the treatment of brain tumors. Early results from a small trial were recently reported Of 63 patients
      NWBO
      GVInvestments GVInvestments 9 minutes ago
      How until they Hit $300 per share? I really want 300 per share.
      FNMA
      Truthsocial Truthsocial 22 minutes ago
      You are hitting the nail right on the head spot on ...facts are facts
      Seems most so called Conspiracy theories have come to be true Facts...that's a Fact
      RDGL
      misterfishman misterfishman 27 minutes ago
      I kid you not i. Can still bench 225 because of it.your going to want to take Dimm with it to block estrogen cause it will increase that as well.
      IGPK
      PC retired PC retired 28 minutes ago
      Dania?, do you mean Denmark?
      ASRE
      go seek go seek 31 minutes ago
      Judge Denise J.Casper is the judge on the Paxlovid lawsuit. Her husband is Marc Casper, CEO of Thermo Fisher Scientific.
      Goggle ‘Thermo Fisher Scientific Pfizer’… There could be a conflict of interest here.

      Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access t
      ENTA
      TheOTCstocksGuy TheOTCstocksGuy 33 minutes ago
      Headed under .50 and lower! Watch and learn...
      XRPUSD
      rx7171 rx7171 33 minutes ago
      Since sleep improvement is neither a primary or secondary trial endpoint we should not expect precise data with a p value.
      AVXL
      Hoghead7 Hoghead7 35 minutes ago
      Check this out!
      https://www.linkedin.com/posts/mark-labarbera-4230924a_working-closely-with-our-partners-at-toyota-activity-7244686263331557377-I8YD?utm_source=share&utm_medium=member_android
      FCEL
      Dead On Arrival Dead On Arrival 35 minutes ago
      You are pathetic.
      NB
      Roddy4 Roddy4 39 minutes ago
      What still is not clear to me is why their are not showing all their cards? They should be interested in having a fair company evaluation by the market.
      ANIP
      oldmystic oldmystic 49 minutes ago
      AVXL Monthly Log: https://invst.ly/172xzb
      AVXL
      Tally1! Tally1! 1 hour ago
      I see more promises like we’ve had last 15 years
      Supposed to start trading Aug then mid Sept then mid Oct now in November and still nothing
      Name change has occurred apparently awaiting on finra to activate but finra know nothing of what is apparently going on
      CDBT
      Tally1! Tally1! 1 hour ago
      I see more promises like we’ve had last 15 years
      Supposed to start trading Aug then mid Sept then mid Oct now in November and still nothing
      Name change has occurred apparently awaiting on finra to activate but finra know nothing of what is apparently going on
      CDBT
      Tally1! Tally1! 1 hour ago
      I see more promises like we’ve had last 15 years
      Supposed to start trading Aug then mid Sept then mid Oct now in November and still nothing
      Name change has occurred apparently awaiting on finra to activate but finra know nothing of what is apparently going on
      CDBT
      TommyJ7651 TommyJ7651 1 hour ago
      Yup, Agnico is definitely one of the best miners out there right now. They have some land packages quite near Duparquet so it would definitely not be to far fetched for them to make a deal with us. Many investors are so focused on Springpole right now it seems they have completely forgotten about Du
      AEM
      gp22 gp22 1 hour ago
      $POET: Nuke play...AI chips for $AMZN, $MSFT & $ORCL Hyper Data Centers. $NNE, $OKLO & $LTBR investors finding too. Link:
      https://poet-technologies.com/news/2024-oct-16.html
      AMZN LTBR MSFT
      linuxmanneke linuxmanneke 1 hour ago
      Some words used by Lebby have reached there expiration dates. If our shareprice was already (again) above 10 at least, you Will never heard me complainig about anything, and I will temper my impatience again... But here we are, at 3.xx after all those years. I spend a lot of money in this Company, a
      LWLG
      janice shell janice shell 1 hour ago
      And very good at this. He convinced quite a few of them to vote for Harris. I think 12...
      fuagf fuagf 1 hour ago
      Pete is very patient.
      janice shell janice shell 2 hours ago
      lolol.... Not totally convinced that grubs offer food for thought, but...
      fuagf fuagf 2 hours ago
      Congratulations all. Lots of food for thought.

      Your Recent History

      AMEX
      AOM
      Moderate Allocation ETF
      BIT
      P223K2
      NLBNPIT223K2 20991231 18...
      Delayed Upgrade Clock